000 01449 a2200397 4500
005 20250513045409.0
264 0 _c19950303
008 199503s 0 0 eng d
022 _a0952-3278
024 7 _a10.1016/0952-3278(94)90007-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZhao, W W
245 0 0 _aPGE2 inhibits acetylcholine release from cholinergic nerves in canine but not equine airways.
_h[electronic resource]
260 _bProstaglandins, leukotrienes, and essential fatty acids
_cNov 1994
300 _a347-55 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAcetylcholine
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aBronchi
_xinnervation
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCyclooxygenase Inhibitors
_xpharmacology
650 0 4 _aDinoprostone
_xpharmacology
650 0 4 _aDogs
650 0 4 _aElectric Stimulation
650 0 4 _aFemale
650 0 4 _aHorses
650 0 4 _aIndomethacin
_xpharmacology
650 0 4 _aMale
650 0 4 _aMeclofenamic Acid
_xpharmacology
650 0 4 _aSpecies Specificity
650 0 4 _aTrachea
_xinnervation
700 1 _aRobinson, N E
700 1 _aYu, M F
773 0 _tProstaglandins, leukotrienes, and essential fatty acids
_gvol. 51
_gno. 5
_gp. 347-55
856 4 0 _uhttps://doi.org/10.1016/0952-3278(94)90007-8
_zAvailable from publisher's website
999 _c7845443
_d7845443